Advanced search

Haptoglobin 2-2, a genetic marker for therapy resistance in established essential hypertension

(1991) In ACTA CARDIOLOGICA 46. p.647-648
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Delanghe, Joris, Daniel Duprez, MARC DE BUYZERE, B Callens, Geert Leroux-Roels, and Denis Clement. 1991. “Haptoglobin 2-2, a Genetic Marker for Therapy Resistance in Established Essential Hypertension.” In , 46:647–648.
APA
Delanghe, Joris, Duprez, D., DE BUYZERE, M., Callens, B., Leroux-Roels, G., & Clement, D. (1991). Haptoglobin 2-2, a genetic marker for therapy resistance in established essential hypertension (Vol. 46, pp. 647–648).
Vancouver
1.
Delanghe J, Duprez D, DE BUYZERE M, Callens B, Leroux-Roels G, Clement D. Haptoglobin 2-2, a genetic marker for therapy resistance in established essential hypertension. 1991. p. 647–8.
MLA
Delanghe, Joris, Daniel Duprez, MARC DE BUYZERE, et al. “Haptoglobin 2-2, a Genetic Marker for Therapy Resistance in Established Essential Hypertension.” Vol. 46. 1991. 647–648. Print.
@inproceedings{224591,
  author       = {Delanghe, Joris and Duprez, Daniel and De Buyzere, Marc and Callens, B and Leroux-Roels, Geert and Clement, Denis},
  issn         = {0001-5385},
  language     = {eng},
  pages        = {647--648},
  title        = {Haptoglobin 2-2, a genetic marker for therapy resistance in established essential hypertension},
  volume       = {46},
  year         = {1991},
}